D. Santos-Ferreira

Protective effects of SGLT-2 inhibitors across the cardiorenal continuum: two faces of the same coin.

F. Ruschitzka, N. Marx, I. Raz, 2021, European journal of preventive cardiology.

SGLT-2 Inhibitors in Heart Failure and Type-2 Diabetes: Hitting Two Birds with One Stone?

R. Fontes-Carvalho, D. Santos-Ferreira, P. Gonçalves-Teixeira, 2019, Cardiology.

Metformin in non-diabetic patients with metabolic syndrome and diastolic dysfunction: the MET-DIME randomized trial

A. Leite-Moreira, V. Gama, R. Fontes-Carvalho, 2021, Endocrine.

Phenotyping patients with ischaemic heart disease at risk of developing heart failure: an analysis of the HOMAGE trial

F. Zannad, B. Pieske, P. Rossignol, 2023, ESC heart failure.

Prognostic value of flow-status in severe aortic stenosis patients undergoing percutaneous intervention

C. Guerreiro, D. Santos-Ferreira, E. Pereira, 2023, The international journal of cardiovascular imaging.